Ali Rezai (neurosurgeon)

The technology of Deep Brain Stimulation is being applied to treat patients afflicted with Parkinson's disease[10] and other movement disorders.

The safety and efficacy of deep brain stimulation is also being studied at the ventral capsule/ventral striatum (VC/VS) region to specifically modulate frontal lobe behavioral and cognitive networks as a novel treatment approach for Alzheimer's disease (AD) patients.[11][12]

• Deep Brain Stimulation Treatment for Drug Addiction: On Nov. 1, 2019, Rezai surgically implanted a deep brain stimulator chip into the nucleus accumbens part of the human brain to reduce human cravings for drugs, particularly opioids.[13] This marked the first time that Deep Brain Stimulation was performed in the United States for drug addiction. [14] The procedure, approved by the US Food and Drug Administration, received funding from the National Institute on Drug Abuse. The patient, Gerod Buckhalter, age 33, was a drug abuser since age 15 and the first of four patients in this pilot program aimed at a small percentage of patients with treatment-resistant cravings for opioids. The operation was a first-in-the-U.S. clinical trial using deep brain stimulation for patients suffering from treatment-resistant opioid use disorder. [15]

• Non-Opioid Medication Treatment: On November 15, 2018, a team of approximately eight medical investigators at The Rockefeller Neuroscience Institute at West Virginia University conducted the nation's first phase III clinical trial using a tiny, pill-like micropellet implant made of a non-addictive, non-steroid medication that was placed into a patient's lower back to combat chronic pain caused from sciatica.[16][17][18]

• Alzheimer's Disease: West Virginia University's Rockefeller Neuroscience Institute has been chosen as the first site in the world to participate in phase II of a new clinical trial using ultrasound technology to help reverse the effects of Alzheimer's disease, and allow doctors access to parts of the brain affected by it.[19][20][21]
• Parkinson's Disease: On May 3, 2016 at the Ohio State Wexner Medical Center, Dr. Ali Rezai and Neurologist Dr. Punit Agarwal performed brain stimulation surgery using an electrical lead attached to a pacemaker to control tremors from Parkinson's disease.[22][23]

Rezai received an undergraduate degree from the University of California, Los Angeles, and graduated with honors from the University of Southern California's School of Medicine to earn his MD degree in 1990. He completed his subspecialty training in functional neurosurgery at the University of Toronto. In 1997, Rezai completed the residency program at [New York University's School of Medicine].

From 2011 to 2013, Rezai was president of the North American Neuromodulation Society. He is a past president of the Congress of Neurological Surgeons and the American Society of Stereotactic and Functional Neurosurgery.[24][25] In September 2017, Rezai was appointed by West Virginia University and the Rockefeller family as the incoming director to lead neuroscience clinical studies and research for the new West Virginia University Rockefeller Neuroscience Institute.[26][4]

• Innovator of the Year Award, Cleveland Clinic, 2007
• Best Article of the Year Award, CNS Spectrums, 2004
• Best Paper of the Year, American Psychiatric Association, 2004
• American Association of Neurological Surgeons William H Sweet Investigator Award, 1998
• Congress of Neurological Surgeons Clinical Fellowship Award, 1997[27]
• Bottrell Neurosurgical Award in Neurosurgery, 1997[28]

• Editorial board, Neurosurgery Journal
• Editorial board, World Neurosurgery Journal
• Editorial board, Stereotactic and Functional Neurosurgery Journal
• Editorial board, Neuromodulation Journal
• Editorial board, Neurological Research Journal
• Co-editor, World Neurosurgery journal supplement, 2013
• Co-editor, Movement Disorders journal supplement, “Deep brain stimulation for Parkinson’s disease”, 2006
• Editor, Neurosurgery Clinics of North America: “Neurosurgery for Psychiatric Disorders”, 2003

• President, North American Neuromodulation Society (NANS), 2011–2013[28]
• President, Congress of Neurological Surgeons (CNS), 2012–2013[29]
• Past president, American Society of Stereotactic and Functional Neurosurgery (ASSFN), June 2010–June 2012[29]
• Annual Meeting Scientific Program chairman, North American Neuromodulation Society Meeting, 2009–2011
• Annual Meeting Program chairman, Congress of Neurological Surgeons Annual Meeting, 2010
• Vice-president, American Society of Stereotactic and Functional Neurosurgery (2008–2010)
• Executive Committee, Congress of Neurological Surgeons, 2002–2013
• Board of Directors, North American Neuromodulation Society, 2004–2013Board of Directors, International Society of Reconstructive Neurosurgery, 2005–2013

Rezai has published more than 175 peer-reviewed articles in peer reviewed journals, including Nature and Lancet Neurology. He serves on the editorial board of five scientific journals, including Neurosurgery.[24]

1. US Patent 6,167,311 - Method of treating psychological disorders by brain stimulation within the thalamus[30]
2. US Patent 6,356,786 - Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain[31]
3. US Patent 6,356,787 - Method of treating facial blushing by electrical stimulation of the sympathetic nerve chain[32]
4. US Patent 6,418,344 - Method of treating psychiatric disorders by electrical stimulation within the orbitofrontal cerebral cortex[33]
5. US Patent 6,438,423 - Method of treating complex regional pain syndromes by electrical stimulation of the sympathetic nerve chain[34]
6. US Patent 6,609,030 - Method of treating psychiatric diseases by neuromodulation within the dorsomedial thalamus[35]
7. US Patent 6,708,064 - Modulation of the brain to affect psychiatric disorders[36]
8. US Patent 6,885,888 - Electrical stimulation of the sympathetic nerve chain[37]
9. US Patent 7,181,288 - Neuromodulation device and method of using the same[38]
10. US Patent 7,454,251- Excess lead retaining and management devices and methods of using same[39]
11. US Patent 7,477,945-Delivery device for stimulating the sympathetic nerve chain[32]
12. US Patent 7,493,168-Electrical stimulation to treat hair loss[40]
13. US Patent 7,532,938-Intraluminal electric assembly[41]
14. US Patent 7,623,927-Modulation of the brain to affect psychiatric disorders[42]
15. US Patent 7,640,063-Methods of treating medical conditions by neuromodulation of the cerebellar pathways[43]
16. US Patent 7,697,991-Methods of treating neurological conditions by neuromodulation of the interhemispheric fibers[44]
17. US Patent 7,715,912- System and method for providing a waveform for stimulating biological tissue[45]
18. US Patent 7,715,924-Adjustable stimulation device and method of using same[46]
19. US Patent 7,725,196-Corpus Collosum neuromodulation assembly[47]
20. US Patent 7,769,470-Neuromodulation device and method of using same[48]
21. US Patent 7,778,704-Electrical stimulation of the sympathetic nerve chain[49]
22. US Patent 7,831,308-Neural stimulation delivery device with independently moveable delivery structures[50]
23. US Patent 7,833,174-Method and apparatus for subcutaneously advancing a device between locations[51]
24. US Patent 7,865,237-Methods and systems of achieving hemodynamic control through Neuromodulation[52]
25. US Patent 7,877,146-Methods of treating medical conditions by neuromodulation of the sympathetic nervous system[53]
26. US Patent 8,046,075-Electrical stimulation of the sympathetic nerve chain[54]
27. US Patent 8,082,033-System and method for providing a waveform for stimulating biological tissue[55]
28. US Patent 8,112,154-Systems and methods for neuromodulation using pre-recorded waveforms[56]
29. US Patent 8,155,744- Neuromodulatory methods for treating pulmonary disorders[57]
30. US Patent 8,190,263- Methods of treating medical conditions by neuromodulation of the cerebellar pathways[58]
31. US Patent 8,229,564- Neuromodulatory Methods for Treating Pulmonary Disorders[57]
32. US Patent 8,364,285- Electrical stimulation of the sympathetic nerve chain[59]
33. US Patent 8,417,345- Corpus callosum neuromodulation assembly[60]
34. US Patent 8,538,536- Methods of improving neuropsychological function in patients with neurocognitive disorders[61]
35. US Patent 8,612,005 –B2 - Neurostimulation for Affecting Sleep Disorders[62]

• “Brain Pacemakers” Presentation to the President of the United States, George W. Bush, July 10, 2007[63]
• “Traumatic Brain Injury: Diagnosis and Treatment” Presentation on Capitol Hill to members of the United States Senate and House of Representatives, June 27, 2007
• “Deep Brain Stimulation.” Presentation to Ohio Governor Ted Strickland. Cleveland Clinic, Cleveland, OH, February 7, 2008
• “Traumatic Brain Injury: Implications” Social Security Administration Hearing, Washington, DC, November 18, 2008
• “Neurological Innovations.” Presentation to Mayor of Cleveland, Frank G. Jackson, April 6, 2009
• “Neuromodulation Overview.” Presentation to Ohio Governor John Kasich. The Ohio State University Medical Center, Columbus, OH, December 2, 2011
• “Neuromodulation and chronic disease” Presentation to the Cabinet of the Governor of Ohio. Ohio Statehouse, Columbus OH, January 20, 2012